WC Bioscience Accelerator Participants

Vasocure
Affiliations
SUNY Downstate Medical Center
Technologies
Therapeutic
Indication
Basic Research
Cardiovascular Disease
Clinical Trials
Education
Nephrology
Oncology
Orphan Diseases
Women’s health
Executive Summary
View/DownloadWebsite
www.vasocuretherapeutics.comAdditional Information
Immigrant-Led
Minority-Led
Woman-Led
Eugene Dinescu
Vasocure is a preclinical-stage vascular therapeutics company with the world’s first peptide to directly treat neointimal disease and atherosclerosis.